<p>Enovix（納斯達克代碼：ENVX - 獲取免費報告）於週四公佈了季度財報。該公司報告每股收益（EPS）為（$0.13），超出市場共識預期的（$0.15）$0.02，Briefing.com 報道。Enovix 的淨利潤率為 -481.35%，股本回報率為 -72.83%。該公司在本季度的收入為 750 萬美元，而分析師的預期為 548 萬美元。在去年同期，該公司的每股收益為（$0.14）。公司的收入同比增長了 98.2%。Enovix 更新了其 2025 年第三季度的指引，預計每股收益為 -0.180 到 -0.140。</p>
<h2>Enovix 股票表現</h2>
<ul>
<li>5 只夏季回購的熱門股票，你可以獲利</li>
</ul>
<p>在週五的午盤交易中，納斯達克：ENVX 下跌了 $2.70，報 $10.70。該公司的股票交易量為 24,263,913 股，而其平均交易量為 10,370,709 股。該公司的市值為 20.5 億美元，市盈率為 -12.74，貝塔值為 2.11。Enovix 的 52 周低點為 $5.27，52 周高點為 $16.49。該公司的 50 日移動平均線為 $10.99，200 日移動平均線為 $9.38。公司的債務與股本比率為 0.71，流動比率為 4.68，速動比率為 4.49。</p>
<h2>分析師設定新目標價</h2>
<p>ENVX 一直是幾份研究分析報告的主題。Craig Hallum 在 7 月 8 日的研究報告中重申了 “買入” 評級，並將 Enovix 的目標價從 $12.00 上調至 $15.00。TD Cowen 在 7 月 7 日的研究報告中將 Enovix 的評級上調至 “持有”，並將其目標價從 $7.00 上調至 $15.00。B. Riley 在 7 月 10 日的研究報告中重申了 “買入” 評級，並將 Enovix 的目標價從 $12.00 上調至 $17.00。Benchmark 在 7 月 25 日的研究報告中將 Enovix 的目標價從 $15.00 上調至 $25.00，並給予該公司 “買入” 評級。最後，摩根大通在 7 月 24 日的研究報告中重申了 “中性” 評級，並將 Enovix 的目標價從 $9.00 上調至 $12.00。一位股票研究分析師對該股票給予了賣出評級，五位給予了持有評級，六位給予了買入評級。根據 MarketBeat 的數據，Enovix 目前的共識評級為 “持有”，共識目標價為 $18.60。</p>
<ul>
<li>Enovix 股價創六個月新高；長期高點將隨之而來</li>
</ul>
<p><strong>閲讀我們最新的 ENVX 股票分析</strong></p>
<h2>Enovix 的機構交易</h2>
<p>幾家機構投資者和對沖基金最近買賣了 ENVX 的股票。高盛集團在第一季度將其在 Enovix 的持股比例提高了 65.4%。高盛集團目前擁有 1,137,777 股該公司的股票，價值 $8,351,000，此前在上個季度購買了額外的 449,934 股。瑞銀資產管理公司（UBS AM）在第一季度將其在 Enovix 的持股比例提高了 18.4%。瑞銀資產管理公司目前擁有 358,023 股該公司的股票，價值 $2,628,000，此前在上個季度購買了額外的 55,676 股。未來資產全球 ETF 持有有限公司在第一季度將其在 Enovix 的持股比例提高了 5.1%。未來資產全球 ETF 持有有限公司目前擁有 98,318 股該公司的股票，價值 $722,000，此前在上個季度購買了額外的 4,780 股。NewEdge Advisors LLC 在第一季度將其在 Enovix 的持股比例提高了 10.4%。NewEdge Advisors LLC 目前擁有 26,257 股該公司的股票，價值 $193,000，此前在上個季度購買了額外的 2,481 股。最後，Caxton Associates LLP 在第一季度購買了 Enovix 的新股份，價值約 $190,000。目前 50.92% 的股票由對沖基金和其他機構投資者持有。</p>
<ul>
<li>3 只有望翻倍的股票——現在仍有時間購買</li>
</ul>
<p>Enovix 宣佈其董事會已於 7 月 2 日授權了一項股票回購計劃，允許公司回購價值 $6000 萬的流通股。該回購授權允許公司通過公開市場購買最多 3.1% 的股票。股票回購計劃通常表明公司的管理層認為其股票被低估。</p>
<h2>關於 Enovix</h2>
<p>（獲取免費報告）</p>
<p>Enovix 公司設計、開發和製造硅負極鋰離子電池。它服務於可穿戴設備和物聯網、智能手機、筆記本電腦和平板電腦、工業和醫療以及電動車行業。該公司成立於 2007 年，總部位於加利福尼亞州弗裏蒙特。</p>
<h2>閲讀更多</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Enovix</li>
<li>2 只有望在 2025 年大幅上漲的 CRM 平台股票</li>
<li>比特幣和股息：這 3 只 ETF 的贏家組合</li>
<li>電動車股票及其獲利方式</li>
<li>PG&amp;E 是 AI 的投資機會嗎？為什麼期權交易者在大舉押注</li>
<li>什麼樣的股票是好的股息股票？</li>
<li>MarketBeat 週迴顧 – 07/28 - 08/01</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RU5WWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RU5WWA"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對本故事有任何問題或意見，請發送電子郵件至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 $1,000 在 Enovix 嗎？</h2>
<p>在你考慮 Enovix 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議現在購買，以便在更廣泛的市場注意到之前……而 Enovix 並不在名單上。</p>
<p>雖然 Enovix 目前在分析師中被評為適度買入，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

ENVX

<p>Enovix（納斯達克代碼：ENVX）報告的季度每股收益為（$0.13），超出預期的（$0.15）$0.02。收入達到 750 萬美元，超過預期的 548 萬美元，同比增長 98.2%。該公司的淨利潤率為-481.35%，股本回報率為-72.83%。Enovix 更新了其 2025 年第三季度的指引，預計每股收益在-0.180 到-0.140 之間。分析師設定的共識目標價為$18.60，評級包括買入、持有和賣出。該公司還授權了一項 6000 萬美元的股票回購計劃</p>

<p>Enovix (NASDAQ:ENVX - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.13) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.02, Briefing.com reports. Enovix had a negative net margin of 481.35% and a negative return on equity of 72.83%. The firm had revenue of $7.50 million during the quarter, compared to analysts' expectations of $5.48 million. During the same period in the prior year, the company posted ($0.14) EPS. The company's revenue was up 98.2% on a year-over-year basis. Enovix updated its Q3 2025 guidance to -0.180--0.140 EPS.</p>
<div class="lb-trans"><p>Enovix（納斯達克代碼：ENVX - 獲取免費報告）於週四公佈了季度財報。該公司報告每股收益（EPS）為（$0.13），超出市場共識預期的（$0.15）$0.02，Briefing.com 報道。Enovix 的淨利潤率為 -481.35%，股本回報率為 -72.83%。該公司在本季度的收入為 750 萬美元，而分析師的預期為 548 萬美元。在去年同期，該公司的每股收益為（$0.14）。公司的收入同比增長了 98.2%。Enovix 更新了其 2025 年第三季度的指引，預計每股收益為 -0.180 到 -0.140。</p>
</div><h2>Enovix Stock Performance</h2>
<div class="lb-trans"><h2>Enovix 股票表現</h2>
</div><ul>
<li>5 Hot Stocks With Summer Buybacks You Can Cash In On</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只夏季回購的熱門股票，你可以獲利</li>
</ul>
</div><p>NASDAQ:ENVX traded down $2.70 during midday trading on Friday, hitting $10.70. The company's stock had a trading volume of 24,263,913 shares, compared to its average volume of 10,370,709. The firm has a market cap of $2.05 billion, a P/E ratio of -12.74 and a beta of 2.11. Enovix has a fifty-two week low of $5.27 and a fifty-two week high of $16.49. The firm's 50 day moving average is $10.99 and its 200-day moving average is $9.38. The company has a debt-to-equity ratio of 0.71, a current ratio of 4.68 and a quick ratio of 4.49.</p>
<div class="lb-trans"><p>在週五的午盤交易中，納斯達克：ENVX 下跌了 $2.70，報 $10.70。該公司的股票交易量為 24,263,913 股，而其平均交易量為 10,370,709 股。該公司的市值為 20.5 億美元，市盈率為 -12.74，貝塔值為 2.11。Enovix 的 52 周低點為 $5.27，52 周高點為 $16.49。該公司的 50 日移動平均線為 $10.99，200 日移動平均線為 $9.38。公司的債務與股本比率為 0.71，流動比率為 4.68，速動比率為 4.49。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析師設定新目標價</h2>
</div><p>ENVX has been the topic of several research analyst reports. Craig Hallum reissued a &#34;buy&#34; rating and set a $15.00 target price (up from $12.00) on shares of Enovix in a research note on Tuesday, July 8th. TD Cowen raised shares of Enovix to a &#34;hold&#34; rating and raised their price objective for the company from $7.00 to $15.00 in a research note on Monday, July 7th. B. Riley reaffirmed a &#34;buy&#34; rating and issued a $17.00 price objective (up from $12.00) on shares of Enovix in a research note on Thursday, July 10th. Benchmark raised their price objective on shares of Enovix from $15.00 to $25.00 and gave the company a &#34;buy&#34; rating in a research note on Friday, July 25th. Finally, JPMorgan Chase &amp; Co. reaffirmed a &#34;neutral&#34; rating and issued a $12.00 price objective (up from $9.00) on shares of Enovix in a research note on Thursday, July 24th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat, Enovix currently has a consensus rating of &#34;Hold&#34; and a consensus target price of $18.60.</p>
<div class="lb-trans"><p>ENVX 一直是幾份研究分析報告的主題。Craig Hallum 在 7 月 8 日的研究報告中重申了 “買入” 評級，並將 Enovix 的目標價從 $12.00 上調至 $15.00。TD Cowen 在 7 月 7 日的研究報告中將 Enovix 的評級上調至 “持有”，並將其目標價從 $7.00 上調至 $15.00。B. Riley 在 7 月 10 日的研究報告中重申了 “買入” 評級，並將 Enovix 的目標價從 $12.00 上調至 $17.00。Benchmark 在 7 月 25 日的研究報告中將 Enovix 的目標價從 $15.00 上調至 $25.00，並給予該公司 “買入” 評級。最後，摩根大通在 7 月 24 日的研究報告中重申了 “中性” 評級，並將 Enovix 的目標價從 $9.00 上調至 $12.00。一位股票研究分析師對該股票給予了賣出評級，五位給予了持有評級，六位給予了買入評級。根據 MarketBeat 的數據，Enovix 目前的共識評級為 “持有”，共識目標價為 $18.60。</p>
</div><ul>
<li>Enovix Shares Hit 6-Month High; Long-Term Highs to Follow</li>
</ul>
<div class="lb-trans"><ul>
<li>Enovix 股價創六個月新高；長期高點將隨之而來</li>
</ul>
</div><p><strong>Read Our Latest Stock Analysis on ENVX</strong></p>
<div class="lb-trans"><p><strong>閲讀我們最新的 ENVX 股票分析</strong></p>
</div><h2>Institutional Trading of Enovix</h2>
<div class="lb-trans"><h2>Enovix 的機構交易</h2>
</div><p>Several institutional investors and hedge funds have recently bought and sold shares of ENVX. Goldman Sachs Group Inc. lifted its stake in Enovix by 65.4% during the first quarter. Goldman Sachs Group Inc. now owns 1,137,777 shares of the company's stock worth $8,351,000 after purchasing an additional 449,934 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Enovix by 18.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 358,023 shares of the company's stock valued at $2,628,000 after buying an additional 55,676 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Enovix by 5.1% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 98,318 shares of the company's stock valued at $722,000 after buying an additional 4,780 shares during the last quarter. NewEdge Advisors LLC lifted its stake in Enovix by 10.4% in the first quarter. NewEdge Advisors LLC now owns 26,257 shares of the company's stock valued at $193,000 after buying an additional 2,481 shares during the last quarter. Finally, Caxton Associates LLP purchased a new stake in Enovix in the first quarter valued at approximately $190,000. 50.92% of the stock is currently owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>幾家機構投資者和對沖基金最近買賣了 ENVX 的股票。高盛集團在第一季度將其在 Enovix 的持股比例提高了 65.4%。高盛集團目前擁有 1,137,777 股該公司的股票，價值 $8,351,000，此前在上個季度購買了額外的 449,934 股。瑞銀資產管理公司（UBS AM）在第一季度將其在 Enovix 的持股比例提高了 18.4%。瑞銀資產管理公司目前擁有 358,023 股該公司的股票，價值 $2,628,000，此前在上個季度購買了額外的 55,676 股。未來資產全球 ETF 持有有限公司在第一季度將其在 Enovix 的持股比例提高了 5.1%。未來資產全球 ETF 持有有限公司目前擁有 98,318 股該公司的股票，價值 $722,000，此前在上個季度購買了額外的 4,780 股。NewEdge Advisors LLC 在第一季度將其在 Enovix 的持股比例提高了 10.4%。NewEdge Advisors LLC 目前擁有 26,257 股該公司的股票，價值 $193,000，此前在上個季度購買了額外的 2,481 股。最後，Caxton Associates LLP 在第一季度購買了 Enovix 的新股份，價值約 $190,000。目前 50.92% 的股票由對沖基金和其他機構投資者持有。</p>
</div><ul>
<li>3 Stocks Set to Double—And There's Still Time to Buy</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只有望翻倍的股票——現在仍有時間購買</li>
</ul>
</div><p>Enovix declared that its Board of Directors has authorized a stock buyback program on Wednesday, July 2nd that allows the company to repurchase $60.00 million in outstanding shares. This repurchase authorization allows the company to buy up to 3.1% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company's management believes its shares are undervalued.</p>
<div class="lb-trans"><p>Enovix 宣佈其董事會已於 7 月 2 日授權了一項股票回購計劃，允許公司回購價值 $6000 萬的流通股。該回購授權允許公司通過公開市場購買最多 3.1% 的股票。股票回購計劃通常表明公司的管理層認為其股票被低估。</p>
</div><h2>About Enovix</h2>
<div class="lb-trans"><h2>關於 Enovix</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.</p>
<div class="lb-trans"><p>Enovix 公司設計、開發和製造硅負極鋰離子電池。它服務於可穿戴設備和物聯網、智能手機、筆記本電腦和平板電腦、工業和醫療以及電動車行業。該公司成立於 2007 年，總部位於加利福尼亞州弗裏蒙特。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>閲讀更多</h2>
</div><ul>
<li>Five stocks we like better than Enovix</li>
<li>2 Rising CRM Platform Stocks That Can Surge Higher in 2025</li>
<li>Bitcoin and Dividends: A Winning Combo in These 3 ETFs</li>
<li>EV Stocks and How to Profit from Them</li>
<li>Is PG&amp;E an AI Power Play? Why Options Traders Are Betting Big</li>
<li>What Makes a Stock a Good Dividend Stock?</li>
<li>MarketBeat Week in Review – 07/28 - 08/01</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Enovix</li>
<li>2 只有望在 2025 年大幅上漲的 CRM 平台股票</li>
<li>比特幣和股息：這 3 只 ETF 的贏家組合</li>
<li>電動車股票及其獲利方式</li>
<li>PG&amp;E 是 AI 的投資機會嗎？為什麼期權交易者在大舉押注</li>
<li>什麼樣的股票是好的股息股票？</li>
<li>MarketBeat 週迴顧 – 07/28 - 08/01</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RU5WWA" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=ENVX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對本故事有任何問題或意見，請發送電子郵件至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Enovix Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 $1,000 在 Enovix 嗎？</h2>
</div><p>Before you consider Enovix, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 Enovix 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議現在購買，以便在更廣泛的市場注意到之前……而 Enovix 並不在名單上。</p>
</div><p>While Enovix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Enovix 目前在分析師中被評為適度買入，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Enovix（NASDAQ:ENVX）公佈季度財報結果